Nicholas Company, Inc.
Source: SEC Form 13F · as of Mar 2026Nicholas Company, Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $329.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$329.5M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 410,238 | $80.9M |
| SNYSanofi | 1,498,990 | $72.2M |
| LLYELI LILLY & Co | 69,981 | $64.4M |
| GMEDGlobus Medical Inc. | 249,449 | $21.5M |
| IQVIQVIA Holdings Inc. | 80,426 | $13.7M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 71,940 | $12.4M |
| JNJJOHNSON & JOHNSON | 49,590 | $12.1M |
| TECHBIO-TECHNE Corp | 182,869 | $9.6M |
| ABTABBOTT LABORATORIES | 88,998 | $9.1M |
| PBHPrestige Consumer Healthcare Inc. | 150,930 | $8.9M |
| ABBVAbbVie Inc. | 38,725 | $8.4M |
| MRKMerck & Co., Inc. | 49,156 | $5.9M |
| AMGNAMGEN INC | 16,415 | $5.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 16,547 | $4.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.